Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate (Q33184380)

23 July 2017

1 reference

title

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate (English)

1 reference

23 July 2017

1 reference

1 reference

Daniel J George

1

1 reference

PubMed ID

12231066

23 July 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

23 July 2017

1 reference

23 July 2017

60

1 reference

23 July 2017

3 Suppl 1

1 reference

23 July 2017

115-21; discussion 122

1 reference

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Dysregulated expression of growth factors and their receptors in the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Growth factors and their receptors: new targets for prostate cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Polypeptide growth factors: roles in normal and abnormal cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Involvement of platelet-derived growth factor in disease: development of specific antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Platelet-derived growth factor expression and stimulation in human meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Platelet-derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901589-3

7 January 2021

10.1016/S0090-4295(02)01589-3

Identifiers

DOI

1 reference

23 July 2017

1 reference

PubMed ID

12231066